KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹25 Cr | ₹-2.39 Cr | ₹-1.91 Cr | ₹-1.24 Cr | ₹-0.90 Cr |
What is the latest Total Non-Current Liabilities ratio of KILITCH DRUGS (INDIA) ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹-2.39 Cr |
| Mar2023 | ₹-1.91 Cr |
| Mar2022 | ₹-1.24 Cr |
| Mar2021 | ₹-0.90 Cr |
How is Total Non-Current Liabilities of KILITCH DRUGS (INDIA) Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹25 Cr | Positive | |
| Mar2024 | ₹-2.39 Cr | Negative | |
| Mar2023 | ₹-1.91 Cr | Negative | |
| Mar2022 | ₹-1.24 Cr | Negative | |
| Mar2021 | ₹-0.90 Cr | - | |
Compare Total Non-Current Liabilities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹617.4 Cr | 13.4% | 0.4% | 6.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,847.0 Cr | 6.8% | -1.5% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,745.0 Cr | 0% | -4.8% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,346.0 Cr | 1.7% | 4.1% | 20.5% | Stock Analytics | |
| CIPLA | ₹107,075.0 Cr | 0.1% | -12.8% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,507.0 Cr | 1.8% | -0.7% | 3.4% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 13.4% |
0.4% |
6.4% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses